Once a pandemic star, consumer products maker The Clorox Company (NYSE: CLX) is now struggling due to tough comparisons, high inflation, and supply chain issues. Wall Street’s Take J.P. Morgan analyst Andrea Faria Teixeira increased her price target on Clorox stock to $126 from $123 but maintained a Sell rating. Meanwhile, Barclays analyst Lauren Lieberman lowered her price target on Clorox to $117 from $132 and reiterated a Sell rating to reflect a more difficult external cost environment.